Santé Laboratories Independently Submits Novel Foods Application for UK Distribution of its Cannabidiol Formulation

Santé Laboratories is confident it independently met requirements requested by the Food Standards Agency (FSA) in the United Kingdom (UK) for its water-based cannabidiol (CBD) formulation in time to the eagerly awaited March 31, 2021 deadline.

The delivery technology, available for private label and through RESET Bioscience, is already making waves in the US marketplace but would be able to be sold in the UK for CBD formulations.

Read more about the announcement here.